Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
Submitted by
admin
on September 30, 2012 - 10:34am
Source:
Yahoo/MarketWire
News Tags:
Astellas
Medivation
Enzalutamide
prostate cancer
Headline:
Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
Do Not Allow Advertisers to Use My Personal information
